Share
News
1 - 2 of 2 news items
-
05 July 2010 /Authorisation and supervision
Notification to medicines manufacturers about reduced testing of raw materials
The Danish Medicines Agency has become aware that there is some uncertainty about the possibility of using reduced testing of raw materials, including active pharmaceutical ingredients (API).
-
26 January 2010 /Authorisation and supervision
New practice for authorisation of contract acceptors on section 39 authorisations
On 1 February 2010, a new practice will apply to the authorisation of contract acceptors on authorisations granted pursuant to section 39 of the Danish Medicines Act (a section 39 authorisation).
